BridgeMD
New treatment option for Infertility
Official title The Efficiency of a New Sperm-Wash Device for Intrauterine Insemination in Couples With Infertility
ClinicalTrials.gov ID: NCT06956287
What this study is testing
- What it's testing
- This study evaluates the effectiveness of a novel sperm-wash device designed to improve outcomes in intrauterine insemination (IUI) for couples with infertility. Traditional sperm preparation methods, such as density gradient centrifugation (DGC), are associated with elevated reactive oxygen species (ROS) levels and increased sperm DNA fragmentation, potentially compromising pregnancy rates.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 50, men only
You may be able to join if
- Males aged between 25 to 50 years.
- Part of a couple diagnosed with infertility.
- Undergoing intrauterine insemination (IUI) treatment.
- Sperm concentration \>15 million/mL, progressive motility \>32%, and total motile sperm count \>40 million after wash.
- Willingness of both partners to participate and provide informed consent.
You likely can't join if
- Known female infertility factors requiring assisted reproductive technologies beyond IUI.
- Severe male factor infertility (e.g., oligoasthenoteratozoospermia).
- Use of donor sperm or oocyte.
- Chronic illness or medications affecting sperm quality.
- Prior participation in another clinical trial within the past 3 months.
The study team makes the final eligibility decision.
Where it's taking place
- Taichung, Taichung City, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 25 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taichung, Taichung City, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.